You are here

Meeting Highlights

We review selected sessions on the questionable benefits of fecal microbiota transplant; intrahepatic cholestasis of pregnancy; weight-loss drugs in combination with intragastric balloon endoscopy; and beta blockers in pancreatic cancer.
John Otrompke

We cover key sessions on hepatitis B, C, and D virus infections, hepatocellular carcinoma, nonalcoholic steatohepatitis, acute hepatic porphyria, and liver growth in polycystic kidney disease.

Walter Alexander

We report on two sessions on atrial fibrillation, two on heart failure, two on hypertension, and one each on endocarditis and ST-elevation myocardial infarction.

Walter Alexander

From ASCO, we report on metastatic castrate-resistant prostate cancer and locally advanced/metastatic renal cell carcinoma.

Walter Alexander

From IHS, we report on complementary and alternative medicine use by patients and practitioners, the effects of biological hemp-derived cannabidiol on PTSD in military veterans, and more.

We report on two presentations on β-thalassemia and myelodysplastic syndromes, three presentations on chronic lymphocytic leukemia, and others on perioperative oral anticoagulation, sickle-cell anemia, diffuse large B-cell lymphoma, and multiple myeloma.

We report on sessions on the dapagliflozin effect on cardiovascular events; angiotensin receptor–neprilysin inhibition for acute decompensated heart failure; rivaroxaban’s effect on thromboembolic events with heart failure, sinus rhythm, and coronary disease; trial results on the withdrawal of pharmacological heart failure therapy in recovered dilated cardiomyopathy; and more from AHA’s November meeting.

Walter Alexander

Summaries of selected sessions from HFSA 2019: clinical effectiveness of sacubitril/valsartan; use of low-dose dopamine; the cost effectiveness of routine surveillance for organ rejection after heart transplant; inotrope therapy survival rates; and adherence rates of patients with multiple prescriptions.

John Otrompke

We review key sessions on multiple myeloma, chronic lymphocytic leukemia, Hodgkin lymphoma, Epstein-Barr virus-positive post-transplant lymphoma, and follicular lymphoma.

Walter Alexander

We review key findings in the areas of prostate cancer, non–small-cell lung cancer, breast cancer, esophageal cancer, pancreatic cancer, leukemias, metastatic colon cancer, and one session on molecular profiling guidance of therapy.

Walter Alexander

We report on sessions on immunotherapies for non–small-cell lung cancer and pancreatic cancer from AACR.

Walter Alexander

Endometriosis, hypoactive sexual desire disorder, neonatal abstinence syndrome, and more from ACOG.

Walter Alexander

Our coverage of this year’s International Liver Congress reviews sessions on hepatitis C, primary biliary cholangitis, nonalcoholic steatohepatitis, homozygous familial hypercholesterolemia, and advanced hepatocellular carcinoma.

Walter Alexander

Key sessions reported on findings in noncardiac surgery, pharmacological agents in the setting of acute coronary syndromes, and cardiotoxicity of cancer therapy.

Walter Alexander

We present sessions on hepatocellular carcinoma and colorectal and pancreatic cancers from ASCO GI.

Walter Alexander

Key sessions from SABCS covered dose intensification, new trial data, and ovarian suppression to preserve fertility.

Walter Alexander

We review key sessions on Hodgkin’s lymphoma, diffuse large B-cell lymphoma, thromboembolism, hemophilia, sickle cell disease, and chronic lymphocytic leukemia.

We review sessions on the association of diuretic use and amputations, albiglutide and cardiovascular outcomes with diabetes and cardiovascular disease, how lorcaserin affects diabetes in overweight patients, how testosterone therapy improves diabetes in hypogonadal men, the pros and cons of gastric bypass surgery, how low-calorie sweeteners affect the gut microbiome, and more.

Walter Alexander

We review sessions on large-scale aspirin and anticoagulation trials, weight loss therapies, fish oil, gout, endocarditis, and cardiomyopathy, with important implications for health care providers.

Walter Alexander

We review key sessions from the 2017 AHA Scientific Sessions that included pharmacological aspects of treatment for peripheral artery disease, type-2 diabetes, percutaneous coronary intervention, atrial fibrillation, and hypertension.

Walter Alexander

This year’s annual ESMO World Congress on Gastrointestinal Cancer paid particular attention to the influence of primary tumor sidedness in colorectal cancer as it affects prognosis and treatment outcomes to meet the growing interest in this theory.

Walter Alexander

Notable American Society of Clinical Oncology sessions focused on prostate cancer, non–small-cell lung cancer, and hepatocellular carcinoma.

Walter Alexander

Subjects at the European Congress of Rheumatology included rheumatoid arthritis and axial spondyloarthritis.

Walter Alexander

At an event focusing on population-health approaches to the opioid epidemic, discussants agreed that better coordination of care, community involvement in finding solutions, and more consistent use of improved pain-control options are required.

J. Stephen McIver

The latest in hepatology research was presented at this year’s European Association for the Study of the Liver (EASL) International Liver Congress.

Walter Alexander

Highlights of the AMCP Annual Meeting included marketplace trends, the affordability crisis, and the issues facing value-based contracting.

John Jesitus MA
Peter Sonnenreich MA

We report on selected research presented at the ACC 66th Annual Scientific Session and Expo, including sessions on proprotein convertase subtilisin/kexin type 9 inhibitors, anti-Xa anticoagulants, and a direct thrombin inhibitor.

Walter Alexander

One clinician’s controversial position against routine use of opioids for chronic pain.

Walter Alexander

We focus on liver-directed cancer therapy and the role of yittrium-90, as well as one clinician’s controversial position against routine use of opioids for chronic pain.

Walter Alexander

We present sessions on establishing key clinical trial outcomes in psoriatic arthritis and on delaying the radiographic progression of ankylosing spondylitis.

Peter Sonnenreich MA
John Jesitus MA

Key sessions on pharmacotherapy clinical trials across a wide span of disease states, including leukemia, graft-versus-host disease, myelofibrosis, multiple myeloma, and sickle cell disease, are reviewed.

Walter Alexander

We review key sessions from the Society for Immunotherapy of Cancer meeting.

Walter Alexander

We review key sessions from the American Heart Association annual meeting.

Walter Alexander

We present sessions on the latest trials and treatments for colorectal cancer from the ESMO World Congress and report on new developments in diagnostics and therapy presented at the European Post-Chicago Melanoma/Skin Cancer Meeting.

Walter Alexander

We report on new developments in diagnostics and therapy presented at the European Post-Chicago Melanoma/Skin Cancer Meeting.

Walter Alexander

We present EULAR sessions on the latest treatments for rheumatic disease with an infliximab biosimilar, certolizumab pegol, secukinumab, and bimekizumab.

We present EULAR sessions on the latest treatments for rheumatic disease with an infliximab biosimilar, certolizumab pegol, secukinumab, and bimekizumab. We also report on significant developments in diabetes presented at ADA’s Scientific Sessions.

Walter Alexander

We report on significant developments in diabetes presented at ADA’s Scientific Sessions.

We review major American Society of Clinical Oncology sessions on breast, pancreatic, ovarian, skin, and brain cancers and multiple myeloma.

Walter Alexander

We report on key Digestive Disease Week sessions that focused on hepatitis C virus and Clostridium difficile infection, colonoscopy preparation, irritable bowel syndrome, and Crohn’s disease.

Walter Alexander

The annual meeting of the AACR attracted 19,500 attendees in New Orleans in April. We review key scientific sessions on early clinical research, including immunotherapies.

Walter Alexander

Key sessions at HemOnc Today covered systemic and locoregional use of immunotherapies.

Walter Alexander

At the cardiology meeting, preventive strategies took center stage.

Walter Alexander

Featured topics: benzhydrocodone, hydrocodone, and an opioid taper program.

Walter Alexander

Featured topics: disruption of the gut microbiome by drugs plus new approaches to depression.

Walter Alexander

The 119th annual meeting of the American Academy of Ophthalmology attracted 28,000 attendees. The authors review key scientific sessions on endophthalmitis, new patient education videos, and ongoing research activities.

Peter Sonnenreich
Janice Zoeller

The annual meeting of the American Society of Hematology drew 25,000 attendees for the presentation of 5,633 abstracts. We review key sessions focusing on newer agents and their efficacy in high-risk leukemia and multiple myeloma populations.

Walter Alexander

We review several key sessions from the European Society for Medical Oncology’s annual congress, including those on emerging immunotherapies for melanoma and non–small-cell lung cancer and on treatments for renal, ovarian, and breast cancer.

Walter Alexander

More than 33,000 cardiologists and allied medical professionals gathered in Rome to share the latest cardiac research. We review key sessions from a wide range of therapeutic areas, including anticoagulation, obesity, and hypercholesterolemia.

Walter Alexander

Key sessions at the meeting covered the effects and relationships of early remission, weight, corticosteroids, and anti-tumor necrosis factor agents in rheumatic diseases.

Walter Alexander
17th World Congress on Gastrointestinal Cancer

We review sessions on metastatic colorectal cancer and hepatocellular carcinoma.

Walter Alexander

We review key research findings on renal cell carcinoma, prostate cancer, melanoma, myelofibrosis, multiple myeloma, and chronic lymphocytic leukemia.

Walter Alexander

We review key sessions on pharmacological treatment, including four on irritable bowel syndrome and others on pancreatitis and Helicobacter pylori infection.

Walter Alexander

Notable sessions at the American Academy of Dermatology meeting focused on pediatric eczema, infantile hemangiomas, and vaccines.

Peter Sonnenreich MA

The 2015 Aging in America Conference featured discussions on managing medication use in elderly patients.

64th Annual Scientific Session and Expo

Topics included a new agent to lower cholesterol and the use of cangrelor, bivalirudin, unfractionated heparin, ticagrelor, and Bendavia for acute coronary syndromes.

Walter Alexander
56th Annual Meeting and Exposition

Key research focused on mantle cell lymphoma, Hodgkin’s lymphoma, human immunodeficiency virus–related lymphoma, myelodysplastic syndrome, and myelofibrosis.

Walter Alexander

The European Cancer Congress, which attracts a range of European cancer groups, reflected intense interest in immunotherapies. we review key sessions, including three on the anti-programmed death-1 agent nivolumab, each in a different disease setting.

Walter Alexander

Among the featured topics: oncolytic immunotherapy, BRAF/MEK inhibition, and a programmed death-1 inhibitor at the Society for Melanoma Research.

Walter Alexander

Among the featured topics: anti­coagulation therapy, an alternative to statins, and endocarditis in the absence of dental antibiotic prophylaxis at the American Heart Association Scientific Sessions.

Walter Alexander

Attendees at the 19th Congress of the European Hematology Association in Milan, Italy, heard reports on new therapies for acute myeloid leukemia, chronic lymphocytic leukemia, β-thalassemia, multiple myeloma, and polycythemia vera.

Walter Alexander

The American Society of Clinical Oncology meeting drew more than 34,600 people to Chicago to learn about the latest research, including studies on lymphoma, pancreatic cancer, colon cancer, melanoma, multiple myeloma, and palliative care.

Walter Alexander

The American Association for Cancer Research meeting included reports on new agents for breast cancer and melanoma.

Walter Alexander

The American Psychiatric Association meeting offered updates on treatments for bipolar depression, autism, and depression.

Walter Alexander

The American College of Cardiology meeting included sessions on heparin versus bivalirudin and a controversy over renal denervation.

Walter Alexander

Attendees at the American Academy of Dermatology meeting found heightened interest in psoriasis treatments.

Walter Alexander
55th Annual Meeting and Exposition
Walter Alexander

Sessions covered metastatic breast cancer, cachexia in non–small-cell lung cancer, recurrent and/or metastatic head and neck squamous-cell carcinoma, and melanoma.

Walter Alexander

In these two major cardiology meetings, the pharmacology emphasis was strong on balancing risks of stroke and bleeding in treating heart attacks and atrial fibrillation.

Walter Alexander

In these two major cardiology meetings, the pharmacology emphasis was strong on balancing risks of stroke and bleeding in treating heart attacks and atrial fibrillation.

Walter Alexander
Agents for Hypertension, Heart Failure, and Acute Myocardial Infarction

Topics include medications used in hypertension, heart failure, renal dysfunction, and myocardial infarction.

Walter Alexander
Therapies for pancreatic, breast, lung, and skin cancers were some of the hot topics at this year’s ASCO meeting.
Walter Alexander
2013 52nd Annual Assembly: Medication Safety
The Emily Jerry Foundation was instrumental in requiring training and certification for pharmacy technicians; and a representative from the institute for Safe Medication Practices discusses “off-the-beaten-track” areas of medication use.
Michele B. Kaufman PharmD, RPh
The International Liver Congress and American Association for Cancer Research
Walter Alexander

Dermatology topics include agents for psoriasis, urticaria, and infantile hemangiomas. The pros and cons of antiplatelet drugs prasugrel (Effient) and ticagrelor (Brilinta) are discussed, and an investigational agent, cangrelor, shows promise in reducing ischemic events when compared with clopidogrel (Plavix).

Walter Alexander

In 2007, there were no medical applications (apps) for mobile devices, but within 3 years, 44 million mobile apps had been downloaded onto electronic devices. this article reviews pingmd and Cancer.net.

Michele B. Kaufman PharmD, RPh

Drug therapies for multiple myeloma, mantle-cell lymphoma, and myelodysplastic syndromes

Walter Alexander
Generic biologics (e.g., biosimilars) and medication safety related to Joint Commission hospital accreditation standards
Michele B. Kaufman PharmD, RPh
Rheumatology topics included therapies for rheumatoid arthritis, psoriatic arthritis, and Behçet’s syndrome. At the TCT meeting, researchers examined the effects of pharmacological strategies for myocardial infarction, along with platelet function testing as a guide to antiplatelet therapy.
Walter Alexander
Therapies for breast cancer, melanoma, lung cancer, and neuroendocrine tumors
Walter Alexander
Topics include drug therapies for venous thromboembolism, hypertension, plaque regression, and the prevention of stent thrombosis.
Walter Alexander
American College of Rheumatology/Association of Rheumatology Health Professionals
Walter Alexander
27th Annual Scientific Meeting and Exposition
Selected ASCO topics include drugs for melanoma, gastrointestinal tumors, non–small-cell lung cancer, and advanced breast cancer. ASH presentations cover ambulatory blood pressure in type-2 diabetes, triple therapy in obese patients, the effect of body mass on cardiovascular outcomes, and a novel glucagon-like peptide agonist for diabetes.
Walter Alexander
Peter Sonnenreich MA
Treating the Pain of Lyme Disease and Adopting Lifestyle Change as Therapy
Walter Alexander

Topics include comparisons of bivalirudin (Angiomax) and unfractionated heparin in reducing bleeding, prasugrel (Effient) and clopidogrel (Plavix) in acute myocardial infarction, aspirin for critical limb ischemia, and mobilized CD34+ cells for angina.

Walter Alexander
Topics include antiplatelet drugs for acute coronary syndrome, renal denervation for hypertension, contrast-induced nephropathy, “e-cigarettes,” and resistant hypertension.
Walter Alexander
Walter Alexander
Peter Sonnenreich MA
46th European Association for the Study of the Liver
Walter Alexander
Three Leading Candidates
Walter Alexander
43rd Annual Meeting & Scientific Exposition